Amicus Therapeutics(FOLD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

FOLD Amicus Therapeutics

Trading 01-13 13:38:17 EST

14.34

+0.06

+0.39%

High14.35	Low14.27	Vol6.37M
Open14.28	D1 Closing14.28	Amplitude0.56%
Mkt Cap4.42B	Tradable Cap4.13B	Total Shares308.53M
T/O91.14M	T/O Rate2.21%	Tradable Shares288.21M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"FOLD","market":"US","secType":"STK","nameCN":"Amicus Therapeutics","latestPrice":14.335,"timestamp":1768329487371,"preClose":14.28,"halted":0,"volume":6368431,"delay":0,"floatShares":288206958,"shares":308533548,"eps":-0.045705,"marketStatus":"Trading","change":0.055,"latestTime":"01-13 13:38:17 EST","open":14.28,"high":14.35,"low":14.27,"amount":91135221.667277,"amplitude":0.005602,"askPrice":14.34,"askSize":17014,"bidPrice":14.33,"bidSize":13917,"shortable":3,"etf":0,"ttmEps":-0.045705,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1768338000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1180584000000,"exchange":"NASDAQ","adjPreClose":14.28,"preHourTrading":{"tag":"盘前","latestPrice":14.27,"preClose":14.28,"latestTime":"09:29 EST","volume":84455,"amount":1203861.09494,"timestamp":1768314599999},"postHourTrading":{"tag":"盘后","latestPrice":14.23,"preClose":14.28,"latestTime":"19:49 EST","volume":71740,"amount":1023756.4025,"timestamp":1768265386787},"volumeRatio":0.79606,"impliedVol":0.0626,"impliedVolPercentile":0.008},"requestUrl":"/m/hq/s/FOLD","defaultTab":"news","newsList":[{"id":"2595725705","title":"It’s Earnings Warning Season. How to Profit From Others’ Misery","url":"https://stock-news.laohu8.com/highlight/detail?id=2595725705","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595725705?lang=en_us&edition=fundamental","pubTime":"2026-01-01 23:00","pubTimestamp":1767279600,"startTime":"0","endTime":"0","summary":"January is an optimistic time of year for investors, but not necessarily for corporate America.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"9c084b36ba0e1e4ad2a94bff2fcea0b7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANF","LU0058720904.USD","FIVE","BK4200","LU0823411888.USD","BK4534","LU2468319806.SGD","REGN","TMUS","BK4139","BK4548","IPAR","LULU","QDEL","LU0114720955.EUR","LU0823434740.USD","LU2362540622.SGD","LU2362541513.USD","HOLX","NVCR","LU1974910355.USD","ALNY","LU2023250504.SGD","STAA","BK4202","DXCM","BK4585","LU0889565916.HKD","LU0320765992.SGD","LU0289739699.SGD","BK4588","GMED","LU0109394709.USD","PCRX","PTCT","FOLD","SLAB","BK4121","LU1917777945.USD","LU0882574055.USD","ORC","CDNA","LU0053666078.USD","LU0823434583.USD","EXAS","LU2237438978.USD","BK4094","AEO","HALO","ILMN","LU2089984988.USD","BK4535","LU2106854487.HKD","LU0823416689.USD","LU1496350502.SGD","IDCC","LU2362541273.HKD","DHR","BK4504"],"gpt_icon":0},{"id":"2595273373","title":"Amicus Therapeutics Cut to Market Perform From Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2595273373","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595273373?lang=en_us&edition=fundamental","pubTime":"2025-12-29 22:04","pubTimestamp":1767017040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FOLD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 29, 2025 09:04 ET (14:04 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOLD"],"gpt_icon":0},{"id":"2595780917","title":"U.S. RESEARCH ROUNDUP-Expedia Group, Hasbro, Palisade Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2595780917","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595780917?lang=en_us&edition=fundamental","pubTime":"2025-12-29 20:58","pubTimestamp":1767013115,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Expedia Group, Hasbro, Palisade Bio Dec 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Expedia","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nL4N3XZ0LN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065170008.USD","MTN","BK4588","BK4201","LU0054578231.USD","BK4142","EXPE","LU2065171402.SGD","BK4585","PRAX","FOLD","LU0320765646.SGD","BK4139","LU0162691827.USD","BK4216","IE00BFMHRM44.USD","LU2065171311.SGD","PALI","HAS","BP","LU1829250122.USD","LU0889565916.HKD","BK4007","LU2065169927.USD","LU1162221912.USD","LU0320765992.SGD","BK4566","LU0072461881.USD","LU0109394709.USD","BK4190"],"gpt_icon":0},{"id":"2595787658","title":"Leerink Downgrades Amicus Therapeutics to Market Perform From Outperform, Adjusts Price Target to $14.50 From $17","url":"https://stock-news.laohu8.com/highlight/detail?id=2595787658","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595787658?lang=en_us&edition=fundamental","pubTime":"2025-12-29 20:10","pubTimestamp":1767010253,"startTime":"0","endTime":"0","summary":"Amicus Therapeutics (FOLD) has an average rating of overweight and mean price target of $14.83, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FOLD"],"gpt_icon":0},{"id":"2593443584","title":"Amicus Therapeutics Chief People Officer David Michael Clark Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2593443584","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593443584?lang=en_us&edition=fundamental","pubTime":"2025-12-24 05:16","pubTimestamp":1766524605,"startTime":"0","endTime":"0","summary":"David Michael Clark, Chief People Officer of Amicus Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amicus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 23, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDLb9CSd2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Amicus Therapeutics Chief People Officer David Michael Clark Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2065171402.SGD","LU2065169927.USD","FOLD","LU2065171311.SGD","LU2065170008.USD"],"gpt_icon":0},{"id":"2593741765","title":"What's Going On With BioMarin Stock On Tuesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2593741765","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593741765?lang=en_us&edition=fundamental","pubTime":"2025-12-24 02:05","pubTimestamp":1766513100,"startTime":"0","endTime":"0","summary":"BioMarin to acquire Amicus for $4.8 billion as analysts see $1 billion peak sales assets, EPS accretion, and stronger long-term rare disease growth.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/23/Biomarin.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/23/Biomarin.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/analyst-stock-ratings/price-target/25/12/49568946/whats-going-on-with-biomarin-stock-on-tuesday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/25/12/49568946/whats-going-on-with-biomarin-stock-on-tuesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU2065171402.SGD","BMRN","IE00B19Z3B42.SGD","LU2065169927.USD","LU2065170008.USD","LU2065171311.SGD","FOLD","BK4139","IE00B19Z3581.USD","BK4566","IE0002270589.USD","IE00B7SZLL34.SGD"],"gpt_icon":0},{"id":"2593438914","title":"Amicus Therapeutics Cut to Neutral From Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2593438914","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593438914?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:44","pubTimestamp":1766411040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FOLD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 22, 2025 08:44 ET (13:44 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOLD"],"gpt_icon":0},{"id":"2593482621","title":"TD Cowen Downgrades Amicus Therapeutics to Hold From Buy, Adjusts PT to $14.50 From $20","url":"https://stock-news.laohu8.com/highlight/detail?id=2593482621","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593482621?lang=en_us&edition=fundamental","pubTime":"2025-12-22 20:14","pubTimestamp":1766405687,"startTime":"0","endTime":"0","summary":"Amicus Therapeutics (FOLD) has an average rating of overweight and mean price target of $15.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FOLD","TD","PT","COWN"],"gpt_icon":0},{"id":"2593510240","title":"U.S. RESEARCH ROUNDUP-Comerica, Heico, Walmart","url":"https://stock-news.laohu8.com/highlight/detail?id=2593510240","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593510240?lang=en_us&edition=fundamental","pubTime":"2025-12-22 15:49","pubTimestamp":1766389793,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Comerica, Heico, WalmartDec 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Comerica, Heico and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nL4N3XS0F2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","AKTX","ALZN","BMBL","CFG","CWAN","BK4516","FITB","FLUT","ANF","CNTX","ELF","IE00B19Z8X17.USD","DKNG","LU0689472784.USD","COF","LEU","GAP","ALLY","HEI","APRE","LU0323591593.USD","AIG","DRI","BMRN","CMA","CCL","FRT","EOSE","LU1116320737.USD","CAG","GOOGL","AXP","AZZ","LU0187121727.USD","LU1951200564.SGD","T","LU0052756011.USD","FISV","CINF","ASB","LU2242649171.HKD","FOLD","LU2275660780.HKD","AFL","BOW","CYTK","BKSY","CUBE","CRSR"],"gpt_icon":1},{"id":"2593644105","title":"Amicus Therapeutics Inc : TD Cowen Cuts to Hold From Buy; Cuts Target Price to $14.5 From $20","url":"https://stock-news.laohu8.com/highlight/detail?id=2593644105","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593644105?lang=en_us&edition=fundamental","pubTime":"2025-12-22 12:48","pubTimestamp":1766378916,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XS03I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU2065170008.USD","LU2065171311.SGD","LU2065169927.USD","LU2065171402.SGD","FOLD"],"gpt_icon":0},{"id":"2593031731","title":"BUZZ-Australia's Dimerix hits 7-month high on $4.8 billion sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2593031731","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593031731?lang=en_us&edition=fundamental","pubTime":"2025-12-22 12:10","pubTimestamp":1766376612,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Dimerix hits 7-month high on $4.8 billion sale** Shares of Dimerix DXB.AX rise as much as 12.5% to A$0.63, its highest level in seven months** Stock touches its biggest intraday pct gain in six months, if gains hold** Biotech co says U.S. listed biotech firm, BioMarin Pharmaceutical BMRN.O to acquire co's U.S. commercial licensing partner, Amicus Therapeutics for $4.8 billion** Amicus Therapeutics is a biopharma co, licensing DXB's drug, DMX-200, for U.S. market to treat rare kidney diseases** Stock up 80.89% YTD, including session's moves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nL6N3XS07Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOLD","IE00B19Z3581.USD","LU2065171311.SGD","BK4139","DXB.AU","IE0002270589.USD","BK7508","BK7067","IE00B7SZLL34.SGD","LU2065171402.SGD","BK4566","BMRN","LU2065170008.USD","LU2065169927.USD","IE00B19Z3B42.SGD","BK7501"],"gpt_icon":0},{"id":"2592940190","title":"Top News Today: Stocks Up as Oracle Deal Quells AI Bubble Fears","url":"https://stock-news.laohu8.com/highlight/detail?id=2592940190","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592940190?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:38","pubTimestamp":1766180280,"startTime":"0","endTime":"0","summary":"TREASURYS: Treasury yields rose during the session, but finished the week lower.COMMODITIES: Oil futures rose Friday, but finished the week lower as traders awaited developments in Venezuela and Ukraine.Consumer Sentiment Rose in December But Remains Dim, Michigan Survey Suggests. This month the survey's headline index rose to 52.9, from 51 in November. A preliminary mid-month December result showed a reading of 53.3, and economists polled by The Wall Street Journal had expected a slight additional increase to 53.5 in the final number.Sales of existing homes rose 0.5% from the prior month to a seasonally adjusted annual rate of 4.13 million, the highest level since February, the National Association of Realtors said Friday. Economists surveyed by The Wall Street Journal had forecast a 0.7% increase.BioMarin Pharmaceutical has struck a deal to buy fellow biotech Amicus Therapeutics for about $4.8 billion in cash, expanding the company's portfolio in treatments for rare diseases.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"fde1f247780922eb8aee4e26cfe5601b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2860962120.EUR","LU1935042215.USD","LU0070302665.USD","LU1989772923.USD","LU0353189763.USD","LU0719512351.SGD","ORCL","LU1989764664.SGD","LU1037948541.HKD","LU0323591593.USD","LU2054465674.USD","LU2896262040.SGD","LU0234570918.USD","LU1069347547.HKD","LU0965508806.USD","LU0348723411.USD","LU0861579265.USD","LU0444971666.USD","LU0476273544.USD","LU0056508442.USD","LU0417517546.SGD","LU2543165471.USD","LU0081259029.USD","BK4516","LU0878866978.SGD","IE00B19Z3B42.SGD","LU0320765489.SGD","LU2357305700.SGD","BK4534","IE00BMPRXR70.SGD","LU2108987350.USD","LU1934455277.USD","SG9999001424.SGD","LU0109392836.USD","IE00B19Z3581.USD","LU0965509283.SGD","LU2360106780.USD","LU0957808578.USD","BK4581","IE00BLSP4452.SGD","LU0444973449.USD","LU1935042488.USD","LU0949170772.SGD","LU1429558221.USD","IE00B3S45H60.SGD","LU1803068979.SGD","LU1934455194.USD","LU0130102774.USD","LU1989772840.SGD","LU1934455863.HKD","LU1642822529.SGD","LU2087625088.SGD","IE0004445239.USD","LU1366333091.USD","LU1035773651.USD","LU2236285917.USD","LU2326559502.SGD","LU1815336760.USD","LU1489326972.SGD","SG9999011175.SGD","BK4097","LU0082616367.USD","LU0175139822.USD","IE00BLSP4239.USD","LU0985489474.SGD","FOLD","LU1935042991.SGD","IE00BMPRXQ63.HKD","LU1201861249.SGD","LU1691799644.USD","LU1989764748.USD","LU0289960550.SGD","LU1366192091.USD","BMRN","LU0198837287.USD","BK4585","LU0889565833.HKD","LU2237957811.SGD","LU0433182093.SGD","LU2746668974.SGD","LU1548497426.USD","LU0965509010.AUD","LU2458330243.SGD","LU1435385759.SGD","LU1506573853.SGD","LU0314106906.USD","BK4528","LU1720051108.HKD","IE0009356076.USD","IE00B775SV38.USD","BK4543","LU0208291251.USD","LU2458330169.SGD","IE00BN8TJ469.HKD","LU1852331112.SGD","LU1935043536.SGD","LU1720051017.SGD","LU0965509101.SGD","LU0661504455.SGD","IE00B7SZLL34.SGD","LU1003077747.HKD","LU2746668461.USD","LU0545039389.USD","IE00BMPRXN33.USD","BK4538","LU0068578508.USD","LU0553294199.USD","LU2237957902.USD","LU0738911758.USD","LU2250418816.HKD","BK4588","LU0648001328.SGD","LU0980610538.SGD","IE00BBT3K403.USD","LU1037948897.HKD","LU1935043023.USD","LU0210536198.USD","LU0353189680.USD","IE0002270589.USD","BK4533","LU0256863811.USD","SG9999003800.SGD","LU0157215616.USD","IE00B5949003.HKD"],"gpt_icon":1},{"id":"2592519191","title":"Amicus Therapeutics Up Over 30%, on Pace for Largest Percent Increase March 2015 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2592519191","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592519191?lang=en_us&edition=fundamental","pubTime":"2025-12-20 02:00","pubTimestamp":1766167200,"startTime":"0","endTime":"0","summary":"Amicus Therapeutics, Inc.  is currently at $14.19, up $3.30 or 30.3%. --Would be highest close since Jan. 2, 2024, when it closed at $14.24. --On pace for largest percent increase since March 19, 2015, when it rose 33.26%. --Up 34.50% this week; best weekly performance since the week ending June 19, 2020, when it rose 39.52%. --Up 50.64% year-to-date; on pace for best year since 2020, when it rose 137.06%. --Down 42.99% from its all-time closing high of $24.89 on Dec. 22, 2020. --Up 44.8% from 52 weeks ago , when it closed at $9.80. --Up 151.6% from its 52-week closing low of $5.64 on June 20, 2025. --Traded as high as $14.36; highest intraday level since Jan. 2, 2024, when it hit $14.53","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOLD","LU2065170008.USD","LU2065169927.USD","LU2065171311.SGD","LU2065171402.SGD","BK4139"],"gpt_icon":0},{"id":"2592991651","title":"Nasdaq Surges Over 1%; Lamb Weston Shares Decline Following Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2592991651","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592991651?lang=en_us&edition=fundamental","pubTime":"2025-12-20 01:16","pubTimestamp":1766164612,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/12/49513626/nasdaq-surges-over-1-lamb-weston-shares-decline-following-q2-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZI","LU0792757196.USD","LU1878469433.USD","PSQ","LU2065170008.USD","QID","LU0786609619.USD","BMRN","BK4585","BK4581",".IXIC","LU2065169927.USD","BK4547","TQQQ","LU1267930573.SGD","MNQmain","IE00B7SZLL34.SGD","TSYW.SI","BK4214","MGRX","BK4139","BK4566","LU0128525929.USD","LU1303367103.USD","USJW.SI","QLD","NVIW.SI","NQmain","IE0002270589.USD","LU0823411888.USD","IE00B19Z3B42.SGD","BK4097","IE00BFXG0V08.USD","LU0889566641.SGD","LU1267930813.SGD","LW","SQQQ","LU0310800379.SGD","BK4534","LU0708994859.HKD","BK4561","LU2065171402.SGD","LU2065171311.SGD","BK4558","FOLD","LU0029864427.USD","USAW.SI"],"gpt_icon":1},{"id":"1142140739","title":"Biogen to Acquire Amicus Therapeutics for $4.8 Billion in Rare Disease Bet","url":"https://stock-news.laohu8.com/highlight/detail?id=1142140739","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142140739?lang=en_us&edition=fundamental","pubTime":"2025-12-20 00:52","pubTimestamp":1766163134,"startTime":"0","endTime":"0","summary":"Biogen (BMRN) announced on Friday its plan to acquire Amicus Therapeutics (FOLD) for approximately $4.8 billion, aiming to expand its footprint in the rare metabolic disease sector. The deal values...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU2065169927.USD","LU2065171402.SGD","BK4566","FOLD","IE0002270589.USD","IE00B7SZLL34.SGD","LU2065171311.SGD","BK4139","IE00B19Z3B42.SGD","LU2065170008.USD","BMRN"],"gpt_icon":0},{"id":"2592196207","title":"Top Midday Stories: Oracle, Others Form JV to Oversee TikTok in US; More Drugmakers to Announce US Drug Price Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2592196207","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592196207?lang=en_us&edition=fundamental","pubTime":"2025-12-20 00:48","pubTimestamp":1766162913,"startTime":"0","endTime":"0","summary":"All three major US stock indexes were up in late-morning trading Friday, as the artificial-intelligence sector looks to regain momentum.In company news, Oracle (ORCL), Silver Lake and MGX have signed ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1fc35ed08d3193e0cb245a1f57cfd89f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1069347547.HKD","LU2746668974.SGD","LU1868836914.USD","IE00BVYPNW00.USD","LU1699723380.USD","LU1803068979.SGD","IE00BFTCPJ56.SGD","IE00BBT3K403.USD","LU0444973449.USD","SG9999002224.SGD","LU1506573853.SGD","LU1868836757.USD","LU0795875086.SGD","LU0265550946.USD","IE00B3PB1722.GBP","LU0661504455.SGD","SG9999014567.USD","LU0965508806.USD","LU0211327993.USD","LU0949170772.SGD","LU2896262040.SGD","BK4566","LU0719512351.SGD","LU1116320737.USD","LU1366333091.USD","LU0029864427.USD","LU1116320901.HKD","LU0985320562.USD","LU1162221912.USD","LU2023250843.SGD","SG9999015952.SGD","LU2065171311.SGD","LU0314106906.USD","LU0708994859.HKD","LU0320765992.SGD","LU1934455194.USD","IE00BDGV0183.EUR","BK4533","LU0965509101.SGD","LU1941712264.USD","LU1032466523.USD","LU2054465674.USD","IE00B5949003.HKD","LU0433182093.SGD","LU1852331112.SGD","GILD","LU2360032135.SGD","LU1935043023.USD","LU0965509010.AUD","IE00B42XCP33.USD","SG9999001440.SGD","LU0889565916.HKD","LU0130102774.USD","LU0823416689.USD","LU2089283258.USD","LU1323610961.USD","LU2087625088.SGD","LU2242646821.SGD","BK4581","LU0348723411.USD","SG9999001176.SGD","LU1989764664.SGD","LU1934455277.USD","LU0198837287.USD","IE0002141913.USD","BK4550","LU1778281490.HKD","LU0310800379.SGD","LU0208291251.USD","LU0985481810.HKD","ABBV","LU1868837136.USD","LU1989764748.USD","SG9999014575.USD","BK4568","LU0068578508.USD","LU0058720904.USD","IE00BMPRXN33.USD","LU1430594728.SGD","LU0310799852.SGD","IE00BN8TJ469.HKD","LU0353189680.USD","BK4007","LU0323591593.USD","LU1989772923.USD","LU0321505868.SGD","IE00BLSP4239.USD","IE00BZ1G4Q59.USD","LU0456855351.SGD","LU0689626769.HKD","LU2108987350.USD","BK4559","LU2112291526.USD","LU2237443549.SGD","LU2360106780.USD","LU2133065610.SGD","BK4516","IE00B775SV38.USD","LU1093756325.SGD","LU1732799900.SGD","LU0320765646.SGD","LU0082616367.USD","LU0210536198.USD","LU0256863902.USD","LU1720051108.HKD","LU2023251221.USD","BK4528","LU2237443465.HKD","IE00B3T34201.USD","LU0238689110.USD","LU1571399168.USD","LU1244550577.SGD","SG9999003800.SGD","LU0256863811.USD","SG9999013999.USD","LU0114720955.EUR","IE00B7SZLL34.SGD","LU1035773651.USD","BK4578","LU2357305700.SGD","LU1691799644.USD","LU1674673428.USD","LU0128525929.USD","LU0432979614.USD","IE00B4R5TH58.HKD","LU0306806265.USD","LU1489326972.SGD","SG9999014542.SGD","LU1934455863.HKD","LU0237698245.USD","LU0211328371.USD","LU1670711123.USD","SG9999011175.SGD","LU2242652126.USD","LU2860962120.EUR","LU0124676726.USD","LU0889565833.HKD","LU0289739699.SGD","LU1989772840.SGD","LU0444971666.USD","LU2106854487.HKD","LU1935042215.USD","SG9999001176.USD","IE00BMPRXQ63.HKD","LU1496350171.SGD","LU1261432733.SGD","LU2237443978.SGD","LU0109392836.USD","LU1366192091.USD","LU1989771016.USD","LU2458330243.SGD","LU0225284248.USD","IE00B3S45H60.SGD","LU1429558221.USD","IE0004445239.USD","LU1066053197.SGD","LU2065171402.SGD","LU0820561909.HKD","LU2065169927.USD","LU0106261372.USD","LU1061106388.HKD","LU1066051811.HKD","LU0943347566.SGD","BK4097","LU0234570918.USD","IE00BJJMRZ35.SGD","LU0096364046.USD","LU0476273544.USD","LU2324357040.USD","LU2065170008.USD","SG9999015358.SGD","LU0985489474.SGD","BK4588","LU1037948541.HKD","LU1935042488.USD","BK4532","LU0175139822.USD","LU0203347892.USD","LU1941712348.USD","LU0006306889.USD","SG9999002232.USD","LU0225771236.USD","LU2361044865.SGD","LU1642822529.SGD","LU2023250504.SGD","LU0882574055.USD","LU1670711040.USD","LU2089984988.USD","LU2237443895.HKD","LU1868837300.USD","IE0009355771.USD","SGXZ57979304.SGD","LU2237443382.USD","LU0158827948.USD","LU1267930490.SGD","LU1720051017.SGD","LU0061475181.USD","LU1037948897.HKD","LU1435385759.SGD","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU2089284900.SGD","LU0957808578.USD","SG9999014559.SGD","LU0130517989.USD","LU1732800096.USD","LU0070302665.USD","LU0738911758.USD","BK4534","LU0234572021.USD","LU1023059063.AUD","IE00BFXG1179.USD","LU0980610538.SGD","LU0321505439.SGD","LU0098860793.USD","LU0203345920.USD","LU0320765489.SGD","LU0109394709.USD","LU1291159041.SGD","MRK","IE00B19Z3B42.SGD","LU1917777945.USD","LU1074936037.SGD","LU2129689514.USD","LU2458330169.SGD","LU2461242641.AUD","IE00BKVL7J92.USD","LU1057294990.SGD","FOLD","LU0081259029.USD","LU2326559502.SGD","BMY","BMRN","LU1066051498.USD","LU1244550221.USD","LU0353189763.USD","LU1267930573.SGD","ORCL","LU2746668461.USD","LU1496350502.SGD","LU1868836591.USD","LU1815336760.USD","LU1201861249.SGD","LU1551013425.SGD","SG9999015945.SGD","LU2250418816.HKD","LU1718418525.SGD","BK4538","LU1674673691.USD","BK4583","LU0878866978.SGD","LU1974910355.USD","LU0820561818.USD","LU2125154778.USD","LU1244550494.USD","LU1839511570.USD","SG9999015978.USD","IE00BMPRXR70.SGD","IE00BJT1NW94.SGD","LU1929549753.HKD","LU1935043536.SGD","LU0157215616.USD","LU1670710588.SGD","LU1548497426.USD","LU0306807586.USD","LU2129689431.USD","LU0868494617.USD","LU0211331839.USD","LU1585245621.USD","LU2087621335.USD","BK4139","LU0265550359.USD","LU0553294199.USD","IE0002270589.USD","IE00B1BXHZ80.USD","SG9999015341.SGD","LU0965509283.SGD","IE00BSNM7G36.USD","LU0477156953.USD","LU2361045086.USD","LU1983299246.USD","LU0861579265.USD","LU2361044949.HKD","LU0648001328.SGD","LU0170899867.USD","LU1066051225.USD","LU2347655156.SGD","LU1003077747.HKD","SG9999001424.SGD","LU2543165471.USD","LU2237957902.USD","IE00BLSP4452.SGD","LU2468319806.SGD","LU0267386448.USD","LU1935042991.SGD","BK4543","LU1093756168.USD","LU1551013342.USD","LU1670710661.SGD","LU0689472784.USD","SG9999015986.USD","LU2125154935.USD","LU0417517546.SGD","LU0122379950.USD","LU0056508442.USD","LU2129689605.HKD","LU0266013472.USD","LU0912757837.SGD","IE0009356076.USD","LU0795875169.SGD","LU2236285917.USD","LU0289960550.SGD","IE00B2B36J28.USD","BK4585","IE00BVYPNV92.GBP","LU2237443622.USD","IE00BGHQF631.EUR","LU0545039389.USD","LU2237957811.SGD"],"gpt_icon":1},{"id":"2592959161","title":"Amicus Therapeutics Inc : Needham Cuts to Hold From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2592959161","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592959161?lang=en_us&edition=fundamental","pubTime":"2025-12-19 23:42","pubTimestamp":1766158944,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nFWN3XP0XE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065169927.USD","LU2065171402.SGD","FOLD","LU2065171311.SGD","BK4139","LU2065170008.USD"],"gpt_icon":0},{"id":"2592597195","title":"Amicus Therapeutics Cut to Neutral From Overweight by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2592597195","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592597195?lang=en_us&edition=fundamental","pubTime":"2025-12-19 23:37","pubTimestamp":1766158620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FOLD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 19, 2025 10:37 ET (15:37 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOLD"],"gpt_icon":0},{"id":"2592986411","title":"Biomarin Shares Rise 8.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592986411","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592986411?lang=en_us&edition=fundamental","pubTime":"2025-12-19 22:32","pubTimestamp":1766154739,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nFWN3XP0NI:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU2065170008.USD","LU2065171311.SGD","BMRN","LU2065169927.USD","IE0002270589.USD","IE00B7SZLL34.SGD","BK4566","LU2065171402.SGD","IE00B19Z3581.USD","FOLD","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2592162672","title":"Amicus Therapeutics Shares Jump 30% Premarket After Biomarin Pharmaceuticals to Acquire Co for $4.8 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2592162672","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592162672?lang=en_us&edition=fundamental","pubTime":"2025-12-19 21:12","pubTimestamp":1766149947,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nL4N3XP10C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B19Z3581.USD","FOLD","LU2065170008.USD","LU2065171402.SGD","IE00B19Z3B42.SGD","BK4139","LU2065169927.USD","IE0002270589.USD","BK4566","IE00B7SZLL34.SGD","BMRN","LU2065171311.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amicusrx.com","stockEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.3536},{"period":"3month","weight":0.7761},{"period":"6month","weight":1.3526},{"period":"1year","weight":0.5831},{"period":"ytd","weight":0.0028}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. The company also develops AT-GAA, a novel treatment paradigm for Pompe disease; and enzyme replacement therapies for Pompe diseases. It has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. The company was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.578947,"avgChangeRate":0.061324},{"month":2,"riseRate":0.5,"avgChangeRate":-0.04086},{"month":3,"riseRate":0.555556,"avgChangeRate":0.039527},{"month":4,"riseRate":0.388889,"avgChangeRate":-0.017744},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.009978},{"month":6,"riseRate":0.631579,"avgChangeRate":0.068706},{"month":7,"riseRate":0.578947,"avgChangeRate":0.084684},{"month":8,"riseRate":0.473684,"avgChangeRate":0.040961},{"month":9,"riseRate":0.368421,"avgChangeRate":-0.011223},{"month":10,"riseRate":0.315789,"avgChangeRate":-0.067456},{"month":11,"riseRate":0.578947,"avgChangeRate":0.061605},{"month":12,"riseRate":0.526316,"avgChangeRate":-0.004164}],"exchange":"NASDAQ","name":"Amicus Therapeutics","nameEN":"Amicus Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amicus Therapeutics(FOLD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Amicus Therapeutics(FOLD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Amicus Therapeutics,FOLD,Amicus Therapeutics股票,Amicus Therapeutics股票老虎,Amicus Therapeutics股票老虎国际,Amicus Therapeutics行情,Amicus Therapeutics股票行情,Amicus Therapeutics股价,Amicus Therapeutics股市,Amicus Therapeutics股票价格,Amicus Therapeutics股票交易,Amicus Therapeutics股票购买,Amicus Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amicus Therapeutics(FOLD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Amicus Therapeutics(FOLD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}